PubMed Health⌕ Search

Biomedical subjects

H R Cama

Publications and source records attributed to H R Cama.

At least 55 records · Page 3Linked to original sources

Preparation, properties and metabolism of 5,6-monoepoxy-3-dehydroretinal.

1. 5,6-Monoepoxy-3-dehydroretinal was synthesized from 3-dehydroretinyl acetate and characterized. 2. When fed to vitamin A-deficient rats, 5,6-monoepoxy-3-dehydroretinal was converted into 5,6-monoepoxy-3-dehydrovitamin A and stored in the liver. 3. It was demonstrated that the rat possesses the necessary enzymes for the reduction and oxidation of 5,6-monoepoxy-3-dehydroretinal to the corresponding alcohol and acid respectively. 4. The biological potency of the epoxy-3-dehydroretinal by the rat-growth assay (determined by USP XIV procedure) was 1.07% of that of vitamin A.

Alcohol Oxidoreductases↗

Preparation, properties and metabolism of retro-3-dehydroretinyl acetate.

1. Treatment of 3-dehydroretinyl acetate with aqueous hydrobromic acid resulted in the formation of retro-3-dehydroretinyl acetate, which, on alkaline hydrolysis, gave the corresponding alcohol. 2. retro-3-Dehydroretinyl acetate was isomerized to 3-dehydrovitamin A when fed to vitamin A-deficient rats. 3. When retro-3-dehydroretinyl acetate was administered orally, it was hydrolysed to retro-3-dehydroretinol in the rat intestine, isomerized to 3-dehydroretinol and esterified before being transported to the liver for storage. 4. When administered intraperitoneally, both 3-dehydrovitamin A and retro-3-dehydrovitamin A were accumulated in liver and other tissues, whereas after enterectomy 3-dehydrovitamin A was not detected anywhere in the body. 5. The small intestine was shown to be the major site of conversion of retro-3-dehydrovitamin A into 3-dehydrovitamin A. 6. The extent of conversion of retro-3-dehydroretinyl acetate into 3-dehydrovitamin A was much smaller than that of the conversion of retro-retinyl acetate into vitamin A. 7. The biological potency of retro-3-dehydroretinyl acetate, determined by the rat-growth assay, was 2.6% of that all-trans-retinyl acetate, when given orally.

Animals↗

Preparation, properties and metabolism of 5,6-monoepoxyretinoic acid.

1. Methyl retinoate has been converted into methyl 5,6-monoepoxyretinoate by reaction with monoperphthalic acid. The epoxy acid ester on alkaline hydrolysis gave 5,6-monoepoxyretinoic acid. 2. Treatment of the 5,6-monoepoxy compounds with ethanolic hydrochloric acid gave the corresponding 5,8-epoxy (furanoid) compounds. 3. With lithium aluminium hydride, the acid and the ester groups were selectively reduced to primary alcohols. 4. Administration of methyl 5,6-monoepoxyretinoate intraperitoneally and subcutaneously had good growth response in vitamin A-deficient rats. 5. 5,6-Monoepoxyretinoic acid, when given intraperitoneally as the sodium salt, was 157% as active as all-trans-retinyl acetate. 6. Methyl 5,6-monoepoxyretinoate was hydrolysed to the epoxy acid by rat-liver homogenate. It had 35% of the biological activity of all-trans-retinyl acetate in the rat when given orally.

Acetates↗

Metabolism and biological potency of retro-retinyl acetate in the rat.

1. retro-Retinyl acetate was shown to exert its biological activity by conversion into vitamin A. 2. When administered orally, retro-retinyl acetate was hydrolysed to retro-retinol in the intestine, isomerized to retinol and esterified before being transported to the liver for storage. 3. Administration of the compound at as high a dose as 4.0mg./day for 4 days led to the accumulation of both vitamin A and retro-vitamin A in the liver. The amount of retro-vitamin A in liver gradually decreased until it was almost completely converted into vitamin A in 18 days. 4. Intraperitoneal administration of the compound led to the accumulation of both vitamin A and retro-vitamin A in liver and other tissues. No vitamin A was detected in any tissue of rats receiving retro-retinyl acetate intraperitoneally after enterectomy. 5. The small intestine is the major site of conversion of retro-vitamin A into vitamin A. The conversion could also be demonstrated by everted intestinal sacs. 6. The biological potency of retro-retinyl acetate determined by the rat-growth assay was 20.5% that of all-trans-retinyl acetate, when given orally.

Acetates↗

Studies on the visual pigment and the indicator yellow analogues formed from 5,6-monoepoxyretinal.

1. A new visual pigment has been isolated from retinae of rats maintained on 5,6-monoepoxyretinal for a period of 6 months. 2. Indicator yellow analogues from 5,6-monoepoxyretinal, namely 5,6-monoepoxyretinylidenemethylamine and 5,6-monoepoxyretinal oxime, have been prepared in a homogeneous state, the latter being obtained crystalline. 5,6-Monoepoxyretinylidenedimethylammonium iodide has also been prepared. 3. The spectroscopic properties, analytical data and antimony trichloride colour reactions of these indicator yellow analogues confirm their Schiff base structure. 4. The nature of chromogens formed from 5,6-monoepoxyretinylideneamino compounds with antimony trichloride and concentrated sulphuric acid is obscure although the chromogens resemble one another very closely. 5. 5,6-Monoepoxyretinylidenemethylamine and 5,6-monoepoxyretinylidenedimethylammonium iodide are very labile, whereas 5,6-monoepoxyretinal oxime is quite stable. 6. Hydrolysis of 5,6-monoepoxyretinylidenemethylamine as a function of pH reveals that, though 5,6-monoepoxyretinylidenemethylammonium ions are stable, the un-ionized compound readily hydrolyses to 5,6-monoepoxyretinal. This hydrolysis can be prevented by excess of un-ionized methylamine and hastened by formaldehyde. 7. The bathochromic shift in the lambda(max.) of the ;acid form' of 5,6-monoepoxyretinylidenemethylamine is due to the formation of its ammonium salt. The spectrum of the ;acid form' is identical with that of 5,6-monoepoxyretinylidenedimethylammonium iodide in ethanol. This is also evidence for the quaternary state of the nitrogen atom during the ;acid shift' of 5,6-monoepoxyretinylidenemethylamine. 8. The significance of 5,6-monoepoxyretinal and the corresponding indicator yellow analogues in the formation and properties of a new visual pigment is discussed.

Animals↗

Metabolism and biologicalpotency of 5,-monoepoxy-beta-carotene and 5,6:5',6'-diepoxy-beta-carotene.

1. 5,6-Monoepoxy-beta-carotene and 5,6:5',6'-diepoxy-beta-carotene were partially converted into the furanoid forms during passage through the rat stomach. 2. The monoepoxide was converted into vitamin A in the small intestine and showed a biological potency 21% of that of beta-carotene. Neither beta-carotene nor 5,6-monoepoxyvitamin A was formed. 3. Intraperitoneal administration of the monoepoxide led to the accumulation of the unchanged compound in the liver and other tissues. 4. The diepoxide gave no beta-carotene or vitamin A or 5,6-monoepoxyvitamin A when given orally and showed no biological potency. 5. The significance of these results with special reference to the mechanism of formation of vitamin A from beta-carotene is discussed.

Animals↗

Absorption, storage and distribution of 3-dehydrovitamin A in the rat.

1. The metabolism of 3-dehydroretinal was found to be similar to that of retinal. It alleviated all the symptoms of vitamin A deficiency, and promoted the growth of vitamin A-deficient rats. 2. When administered orally, 3-dehydroretinal was reduced in the intestine of the rat and subsequently esterified and transported to the liver, where it was stored mainly as the higher fatty acid ester. 3. Intraperitoneal administration of the compound led to the accumulation of 3-dehydrovitamin A in liver and other tissues. Subcutaneous administration of the compound showed a good growth response in the rat. 4. The ratio of 3-dehydroretinyl higher fatty acid ester to 3-dehydroretinol in liver, in the post-absorptive state, was nearly 93:7. 5. There was a linear relationship between the 3-dehydroretinol concentrations of blood and liver of rats. 6. Administration of 3-dehydroretinal at a dosage of 7.5mg./day for 3 days brought about hypervitaminosis A in the rat. 7. The maximal retention of 3-dehydrovitamin A by the kidneys was at an optimum dosage of 4.5mg./day for 3 days.

Animals↗